Body shape throughout life and correlations with IGFs and GH

被引:62
作者
Schernhammer, Eva S.
Tworoger, Shelley S.
Eliassen, A. Heather
Missmer, Stacey A.
Holly, Jeff M.
Pollak, Michael N.
Hankinson, Susan E.
机构
[1] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med,Channing Lab, Boston, MA 02115 USA
[2] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA USA
[3] LBI ACR Vienna, ACR ITR Vienna, Vienna, Austria
[4] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Obstet Gynecol & Reprod Biol, Boston, MA USA
[5] Univ N Bristol, Southmead Hosp, Dept Clin Sci, Bristol, Avon, England
[6] McGill Univ, Dept Med Oncol, Montreal, PQ, Canada
关键词
D O I
10.1677/ERC-06-0080
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Both insulin-like growth factors (IGF) and body size have been linked to premenopausal breast cancer risk. However, observational studies of IGF have not been consistent, and they suggest that perhaps earlier levels of IGF might be more strongly related to breast cancer than those measured at mid-age. We therefore sought to explore associations between several measures of body size throughout life and IGF levels in premenopausal women. We examined cross-sectional associations of birth weight, body shape (or somatotype) at ages 5 and 10, body mass index (BMI) at age 18 and adulthood, bra cup size at age 20, adult waist circumference and waist-to-hip ratio (WHR), and attained height with plasma levels of IGF-I, lGF binding protein 3 (IGFBP-3), IGFBP-1, and GH. Participants were 592 healthy premenopausal women aged 34-52 from the Nurses' Health Study II. Using multiple linear regression, we computed least-square mean hormone levels across the categories of early life anthropometric factors. We observed consistent and strong inverse associations between body shape at various stages in life and IGF levels. Somatotype at ages 5 and 10 was inversely associated with IGF-l (P for difference, < 0.01) and positively with IGFBP-3 measured later in adulthood. Further, comparing women with a BMI >= 25 kg/m(2) at age 18 vs < 19 kg/m(2), similar associations were observed for IGF-I (P for trend, 0.005) and IGFBP-3 (P for trend, 0.01), which were even stronger for BMI at blood collection (BMI < 20 versus BMI >= 30, mean IGF-I 254 ng/ml, 95% CI, 239-271 vs 208 ng/ml, 95% CI, 195-222). Both waist circumference and WHR were strongly and inversely related to IGFBP-1 levels (top versus bottom quartile of waist circumference: 14.5 vs 40.0 ng/ml, P for trend 0.0005; WHR: 18.3 vs 39.4 ng/ml, P for trend 0.002), with similar results for bra cup size at age 20 although they did not reach statistical significance. There was no association between height and IGF or GH levels. Birth weight, on the other hand, was weakly positively associated with both IGF-I and IGFBP-1 levels, and inversely with GH. Our results suggest that childhood and adult body size may affect premenopausal breast cancer risk differently than birth weight, through associations with IGF and GH levels.
引用
收藏
页码:721 / 732
页数:12
相关论文
共 82 条
[1]   Birth weight and risk of breast cancer in a cohort of 106,504 women [J].
Ahlgren, M ;
Sorensen, T ;
Wohlfahrt, J ;
Haflidadóttir, A ;
Holst, C ;
Melbye, M .
INTERNATIONAL JOURNAL OF CANCER, 2003, 107 (06) :997-1000
[2]   A prospective study of serum insulin-like growth factor-I (IGF-I), IGF-II, IGF-binding protein-3 and breast cancer risk [J].
Allen, NE ;
Roddam, AW ;
Allen, DS ;
Fentiman, IS ;
Silva, ID ;
Peto, J ;
Holly, JMP ;
Key, TJ .
BRITISH JOURNAL OF CANCER, 2005, 92 (07) :1283-1287
[3]  
[Anonymous], 1989, Applied Logistic Regression
[4]   Body fatness during childhood and adolescence and incidence of breast cancer in premenopausal women: a prospective cohort study [J].
Baer, HJ ;
Colditz, GA ;
Rosner, B ;
Michels, KB ;
Rich-Edwards, JW ;
Hunter, DJ ;
Willett, WC .
BREAST CANCER RESEARCH, 2005, 7 (03) :R314-R325
[5]   Perinatal exposures and breast cancer risk in the Western New York Exposures and Breast Cancer (WEB) Study [J].
Barba, M ;
McCann, SE ;
Nie, J ;
Vito, D ;
Stranges, S ;
Fuhrman, B ;
Trevisan, M ;
Muti, P ;
Freudenheim, JL .
CANCER CAUSES & CONTROL, 2006, 17 (04) :395-401
[6]   Prenatal and postnatal milk supplementation and adult insulin-like growth factor I: Long-term follow-up of a randomized controlled trial [J].
Ben-Shlomo, Y ;
Holly, J ;
McCarthy, A ;
Savage, P ;
Davies, D ;
Smith, GD .
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2005, 14 (05) :1336-1339
[7]   An investigation of fetal, postnatal and childhood growth with insulin-like growth factor I and binding protein 3 in adulthood [J].
Ben-Shlomo, Y ;
Holly, J ;
McCarthy, A ;
Savage, P ;
Davies, D ;
Gunnell, D ;
Smith, GD .
CLINICAL ENDOCRINOLOGY, 2003, 59 (03) :366-373
[8]   C-peptide, IGF-I, sex-steroid hormones and adiposity:: a cross-sectional study in healthy women within the European Prospective Investigation into Cancer and Nutrition (EPIC) [J].
Bezemer, ID ;
Rinaldi, S ;
Dossus, L ;
van Gils, CH ;
Peeters, PHM ;
Noord, PAH ;
Bueno-de-Mesquita, HB ;
Johnsen, SP ;
Overvad, K ;
Olsen, A ;
Tjonneland, A ;
Boeing, H ;
Lahmann, PH ;
Linseisen, J ;
Nagel, G ;
Allen, N ;
Roddam, A ;
Bingham, S ;
Khaw, KT ;
Kesse, E ;
Téhard, B ;
Clavel-Chapelon, F ;
Agudo, A ;
Ardanaz, E ;
Quiros, JR ;
Amiano, P ;
Martínez-Garcia, C ;
Tormo, MJ ;
Pala, V ;
Panico, S ;
Vineis, P ;
Palli, D ;
Tumino, R ;
Trichopoulou, A ;
Baibas, N ;
Zilis, D ;
Hémon, B ;
Norat, T ;
Riboli, E ;
Kaaks, R .
CANCER CAUSES & CONTROL, 2005, 16 (05) :561-572
[9]  
BLUM WF, 1993, J CLIN ENDOCR METAB, V76, P1610, DOI 10.1210/jc.76.6.1610
[10]   The insulin-like growth factor-I response to growth hormone is increased in prepubertal children with obesity and tall stature [J].
Bouhours-Nouet, Natacha ;
Gatelais, Frederique ;
Boux de Casson, Florence ;
Rouleau, Stephanie ;
Coutant, Regis .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2007, 92 (02) :629-635